SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0000950123-09-058535
Filing Date
2009-11-05
Accepted
2009-11-05 17:17:06
Documents
5
Period of Report
2009-09-30
Filing Date Changed
2009-11-05

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q g20793e10vq.htm 10-Q 1417248
2 EX-31.1 g20793exv31w1.htm EX-31.1 9027
3 EX-31.2 g20793exv31w2.htm EX-31.2 9032
4 EX-32.1 g20793exv32w1.htm EX-32.1 3758
5 EX-32.2 g20793exv32w2.htm EX-32.2 3776
  Complete submission text file 0000950123-09-058535.txt   1444209
Mailing Address 501 FIFTH ST BRISTOL TN 37620
Business Address 501 FIFTH ST BRISTOL TN 37620 4239898000
KING PHARMACEUTICALS INC (Filer) CIK: 0001047699 (see all company filings)

IRS No.: 541684963 | State of Incorp.: TN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15875 | Film No.: 091162051
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1